1. AB0166 Tracking of mucocutanous and musculoskeletal flares in sle using serum fas, ferritin, igfbp2 and stnfrii. (12th June 2018) Authors: Soliman, S.; Vanarsa, K.; Swilling, A.; Merrill, J.; Mohan, C. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Changes in Quality of Life in the First 5 Years of Disease in a Multicenter Cohort of Patients With Systemic Lupus Erythematosus. Issue 9 (September 2014) Authors: Urowitz, M.; Gladman, D. D.; Ibañez, D.; Sanchez‐Guerrero, J.; Bae, S. C.; Gordon, C.; Fortin, P. R.; Clarke, A.; Bernatsky, S.; Hanly, J. G.; Wallace, D. J.; Isenberg, D.; Rahman, A.; Merrill, J.; Ginzler, E.; Alarcón, G. S.; Fessler, B.; Khamashta, M.; Steinsson, K.; Petri, M. Journal: Arthritis care & research Issue: Volume 66:Issue 9(2014:Sep.) Page Start: 1374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cocaine and crack. Issue 6703 (30th September 1989) Authors: Patel, A. R.; Merrill, J.; Vidyasagar, H. N.; Kahn, A. Journal: BMJ Issue: Volume 299:Issue 6703(1989) Page Start: 856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0287 Serologic evidence of viral reactivation and increased disease activity in patients with systemic lupus erythematosus. (12th June 2018) Authors: Wood, R.; Guthridge, L.; Thurmond, E.; Guthridge, C.; Chen, H.; deJager, W.; Macwana, S.; Bourn, R.L.; Kamp, S.; Lu, R.; Arriens, C.; Chakravarty, E.F.; Thanou, A.; Merrill, J.; Guthridge, J.; James, J.A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP0184 Efficacy and Safety of Tabalumab in Patients with Systemic Lupus Erythematosus (SLE): Results from 2 Phase 3, 52-Week, Multicenter, Randomized, Placebo-Controlled Trials. (9th June 2015) Authors: Isenberg, D.; Merrill, J.; Hoffman, R.; Linnik, M.; Morgan-Cox, M.; Veenhuizen, M.; Iikuni, N.; Dickson, C.; Silk, M.; Wallace, D.; Dörner, T. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0185 Significant Clinical Improvement and Reduction of Severe Flares Following Administration of an IL-6 Monoclonal Antibody in Systemic Lupus Erythematosus (SLE) Subjects with High Disease Activity. (9th June 2015) Authors: Smolen, J.; Popa, S.; Szombati, I.; Wallace, D.; Petri, M.; Lipsky, P.; Merrill, J.; Strand, V.; Healey, P.; Li, C.; Christensen, J.; Diehl, A.; Beebe, J.; Vincent, M.; Wajdula, J.; Sridharan, S. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0450 Estimating duration of response in systemic lupus erythematosus trials. (12th June 2018) Authors: Kim, M.; Merrill, J.; Kalunian, K.; Hanrahan, L.; Izmirly, P. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients. Issue 1 (8th December 2017) Authors: Isenberg, D.; Sturgess, J.; Allen, E.; Aranow, C.; Askanase, A.; Sang‐Cheol, B.; Bernatsky, S.; Bruce, I.; Buyon, J.; Cervera, R.; Clarke, A.; Dooley, Mary Anne; Fortin, P.; Ginzler, E.; Gladman, D.; Hanly, J.; Inanc, M.; Jacobsen, S.; Kamen, D.; Khamashta, M. Journal: Arthritis care & research Issue: Volume 70:Issue 1(2018) Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗